Feature Type | Standardized | Nominal ANOVA | ||||
---|---|---|---|---|---|---|
mRNA | AC55649 | CTRPv2 | pan-cancer | AAC | 0.0057 | 0.9 |
mRNA | BRD9647 | CTRPv2 | pan-cancer | AAC | -0.0054 | 0.9 |
mRNA | SU11274 | CTRPv2 | pan-cancer | AAC | -0.0047 | 0.9 |
mRNA | skepinone-L | CTRPv2 | pan-cancer | AAC | 0.0068 | 0.9 |
mRNA | Erlotinib | gCSI | pan-cancer | AAC | 0.0074 | 0.9 |
mRNA | ML162 | CTRPv2 | pan-cancer | AAC | 0.0041 | 0.9 |
mRNA | niclosamide | CTRPv2 | pan-cancer | AAC | -0.0043 | 0.9 |
mRNA | BRD-K07442505 | CTRPv2 | pan-cancer | AAC | 0.0044 | 0.9 |
mRNA | KX2-391 | CTRPv2 | pan-cancer | AAC | 0.0037 | 0.9 |
mRNA | Dasatinib | CTRPv2 | pan-cancer | AAC | -0.0042 | 0.9 |